Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

77.47 USD +0.81 (+1.06%)
Official Closing Price Updated: 7:59 PM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Merck & Co

< Previous 1 2 3 4 5 6 7 8 9
...
80 81 Next >
Merck Presents Results from Phase 1 Trial Evaluating Investigational Islatravir Subdermal Implant for the Prevention of HIV-1 Infection at CROI 2021
Merck Presents Results from Phase 1 Trial Evaluating Investigational Islatravir Subdermal Implant for the Prevention of HIV-1 Infection at CROI 2021 
From Business Wire News Releases
Health Canada Approves KEYTRUDA® (pembrolizumab) as First-line Treatment for Adults with Metastatic Microsatellite Instability-High or Mismatch Repair Deficient Colorectal Cancer
From PR Newswire
Ridgeback Biotherapeutics and Merck Announce Preliminary Findings from a Phase 2a Trial of Investigational COVID-19 Therapeutic Molnupiravir
Ridgeback Biotherapeutics and Merck Announce Preliminary Findings from a Phase 2a Trial of Investigational COVID-19 Therapeutic Molnupiravir 
From Business Wire News Releases
Merck Announces Fifth Round of Global Grants to Tackle Maternal Mortality and Promote Health Equity Worldwide
Tags Health & Healthcare Community Involvement Merck
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Merck Begins Tender Offer to Acquire Pandion Therapeutics
Merck Begins Tender Offer to Acquire Pandion Therapeutics 
From Business Wire News Releases
Merck to Present at the Barclays Global Healthcare Conference
Merck to Present at the Barclays Global Healthcare Conference 
From Business Wire News Releases
Merck to Present New Data from Various HIV Research and Development Programs at CROI 2021
Merck to Present New Data from Various HIV Research and Development Programs at CROI 2021 
From Business Wire News Releases
Merck to Help Produce Johnson & Johnson’s COVID-19 Vaccine; BARDA to Provide Merck With Funding to Expand Merck’s Manufacturing Capacity for COVID-19 Vaccines and Medicines
Merck to Help Produce Johnson & Johnson’s COVID-19 Vaccine; BARDA to Provide Merck with Funding to Expand Merck’s Manufacturing Capacity 
From Business Wire News Releases
Merck Announces Fifth Round of Global Grants to Tackle Maternal Mortality and Promote Health Equity Worldwide
Merck Announces Fifth Round of Global Grants to Tackle Maternal Mortality and Promote Health Equity Worldwide 
From Business Wire News Releases
PANDION THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Pandion Therapeutics, Inc. - PAND
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Pandion Therapeutics, Inc. (NasdaqGS: PAND) to... 
From Business Wire News Releases
Merck Provides Update on KEYTRUDA® (pembrolizumab) Indication in Metastatic Small Cell Lung Cancer in the US
Merck Provides Update on KEYTRUDA® (pembrolizumab) Indication in Metastatic Small Cell Lung Cancer in the US 
From Business Wire News Releases
U.S. FDA Accepts Merck’s Gefapixant New Drug Application for Review
U.S. FDA Accepts Merck’s Gefapixant New Drug Application for Review 
From Business Wire News Releases
Merck Animal Health Completes Acquisition of Poultry Sense Limited
Merck Animal Health Completes Acquisition of Poultry Sense Limited 
From Business Wire News Releases
SHAREHOLDER ALERT: WeissLaw LLP Investigates Pandion Therapeutics, Inc.
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Pandion Therapeutics, Inc. ("Pandion" or the "Company") (NASDAQ: PAND) in... 
From PR Newswire
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Pandion Therapeutics, Inc. Buyout
From GlobeNewswire News Releases
PANDION ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PAND and Encourages Investors to Contact the Firm
From GlobeNewswire News Releases
Merck to Acquire Pandion Therapeutics
Merck to Acquire Pandion Therapeutics 
From Business Wire News Releases
Merck to Present at the Cowen 41st Annual Health Care Conference
Merck to Present at the Cowen 41st Annual Health Care Conference 
From Business Wire News Releases
Thanks to Accelerated COVID-19 Research, New Therapeutic Vaccines May Soon Be Upon Us
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Thanks to Accelerated COVID-19 Research, New Therapeutic Vaccines May Soon Be Upon Us
FN Media Group Presents USA News Group News Commentary 
From PR Newswire
Independent Data Monitoring Committee Concludes OlympiA Trial of LYNPARZA® (olaparib) Crossed Superiority Boundary for Invasive Disease-Free Survival vs. Placebo at Planned Interim Analysis
Independent Data Monitoring Committee Concludes OlympiA Trial of LYNPARZA Crossed Superiority Boundary of Invasive Disease-Free Survival vs. Placebo 
From Business Wire News Releases
BioSig Appoints Brenda Castrodad to Lead Human Resources
Seasoned medtech executive to scale up the Company’s organizational development upon the increase in demand for the evaluative installations of the PURE EP System™ 
From GlobeNewswire News Releases
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrated Superior Progression-Free Survival (PFS) and Overall Survival (OS) Versus Sunitinib as First-Line Treatment for Patients With Advanced
KEYTRUDA Plus LENVIMA Demonstrated Superior PFS and OS Versus Sunitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma 
From Business Wire News Releases
Merck Announces Fourth-Quarter and Full-Year 2020 Financial Results
Merck Announces Fourth-Quarter and Full-Year 2020 Financial Results 
From Business Wire News Releases
Kenneth C. Frazier to Retire as Merck CEO; Board Elects Robert M. Davis as Successor; Frazier to Continue as Executive Chairman
Kenneth C. Frazier to Retire as Merck CEO; Board Elects Robert M. Davis as Successor; Frazier to Continue as Executive Chairman 
From Business Wire News Releases
Merck Named to FORTUNE's List of World's Most Admired Companies
Tags Most Admired Companies Fortune's Most Admired Companies NYSE:MRK
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Dr. Stephen Mayo Elected to Merck Board of Directors
Dr. Stephen Mayo Elected to Merck Board of Directors 
From Business Wire News Releases
Merck Receives Positive EU CHMP Opinion for Expanded Approval of KEYTRUDA® (pembrolizumab) in Certain Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
Merck Receives Positive EU CHMP Opinion for Expanded Approval of KEYTRUDA in Certain Patients With Relapsed or Refractory Classical Hodgkin Lymphoma 
From Business Wire News Releases
Merck Earns Top Marks in Human Rights Campaign's 2021 Corporate Equality Index
Tags Inc/ Reduced Inequalities NYSE:MRK
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Merck Presents Results From Head-to-Head Phase 3 KEYNOTE-598 Trial Evaluating KEYTRUDA® (pembrolizumab) in Combination With Ipilimumab Versus KEYTRUDA Monotherapy in Certain Patients With Metastatic N
Merck Presents Results From Head-to-Head Phase 3 KEYNOTE-598 Trial Evaluating KEYTRUDA Plus Ipilimumab Versus KEYTRUDA Monotherapy in Metastatic NSCLC 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
80 81 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account